summary
Introduced
03/11/2026
03/11/2026
In Committee
03/11/2026
03/11/2026
Crossed Over
Passed
Dead
Introduced Session
119th Congress
Bill Summary
A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
AI Summary
This bill, titled the "Safeguarding Women from Chemical Abortion Act," proposes to withdraw the approval for the drug mifepristone, commonly known as Mifeprex or RU-486, when it is intended for the termination of intrauterine pregnancies, effectively making its sale and distribution for this purpose illegal under the Federal Food, Drug, and Cosmetic Act. Furthermore, it establishes a federal legal claim, or "tort," allowing individuals who experience physical or mental harm from using mifepristone for pregnancy termination to sue the manufacturers for damages, including compensatory and punitive damages, and attorney fees, without preventing states from offering additional legal remedies. The bill also clarifies that it does not alter existing laws related to the mailing of abortifacients.
Committee Categories
Health and Social Services
Sponsors (5)
Last Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 03/11/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/119th-congress/senate-bill/4066/all-info |
| BillText | https://www.congress.gov/119/bills/s4066/BILLS-119s4066is.pdf |
Loading...